Britain begins review to speed access to new drugs

November 20, 2014 12:23 PM

9 0

LONDON (Reuters) - The British government has launched a review to speed the path to market for new drugs and medical devices in an attempt to improve patient care and make the country a more attractive place for investment in life sciences.

British manufacturing relies heavily on the pharmaceuticals sector, including domestic giants GlaxoSmithKline and AstraZeneca, but companies complain that the state-run National Health Service (NHS) is too slow to adopt new treatments.

Also read: Trump might nominate former pharma exec Alex Azar as next Health Secretary

Read more

To category page